Takes years, or money up front, before it pays off
Costs or disruption come first and benefits arrive later. This matters most when needs are urgent or funding may not last through the transition, and less when a gradual change is acceptable.
Under your mix of paths
Caused or worsened by these paths
A cost these paths share. Each path's page says how it applies there.
Staged age expansion takes many years to reach universal coverage.
Enforcing rules against dominant PBM firms is slow.
Competition measures work slowly, and many markets are already concentrated beyond repair.
Hospital breakups are slow and rare.
Establishing public drug manufacturing can be slow and costly.
Funding domestic drug manufacturing involves a slow and costly onshoring process.
Additional residency positions take years before they yield more practicing physicians.
Changing payments toward primary care takes years to change the workforce mix.
Expanded nursing education takes years to increase the workforce.
Spending on housing, nutrition, and public health takes years to show results.
Wage replacement, retraining, and job placement for displaced billing workers are costly.
Higher payment rates do not add mental health clinicians quickly.
Moving from large institutions to small homes and home care brings transition costs.
Buying out for-profit hospice providers is costly.
Enforcing record-sharing standards is slow, and vendors may comply only minimally.
Expanding workforce and facilities before universal coverage is costly up front and slow.
Regional allocation through a separate capital budget can involve slow approvals.
Phasing payment rates in gradually delays savings.
Reducing clinicians’ costs through complementary reforms is slow, so the income protection takes time to arrive.
Moving groups in stages extends the time before the new system delivers its full savings.
Testing state systems before expanding nationally makes the transition slow.
Public evidence review, appeals, and reconsideration make coverage decisions slow.
Scientific peer review makes research funding decisions slow.
Collecting outcome and prescribing evidence by clinician type takes years.
Requiring supervised hours before independence slows the addition of independent practitioners.
Introducing tighter staffing ratios in stages delays their benefits.